Pierre Decazes

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Venues

Diagnostics (Basel, Switzerland)

Blood advances

Oncoimmunology

European radiology

This page only lists publications with an associated author ORCID identifier.

Publications

Vincent Camus, Mathieu Viennot, Pierre-Julien Viailly, Fanny Drieux, Elena-Liana Veresezan, Victor Bobée, Vinciane Rainville, Elodie Bohers, Pierre Sesques, Corinne Haioun, Eric Durot, Michael Bayaram, Cédric Rossi, Laurent Martin, Dominique Penther, Sophie Kaltenbach, Julie Bruneau, Jérôme Paillassa, Olivier Tournilhac, Nicolas Gower, Alexandre Willaume, Chloe Antier, Richard Greil, Emilie Leveque, Pierre Decazes, Stéphanie Becker, David Tonnelet, Philippe Gaulard, Hervé Tilly, Thierry Molina, Alexandra Traverse-Glehen, Marie Donzel, Philippe Ruminy, Fabrice Jardin
Identification of primary mediastinal B-cell lymphomas with higher clonal dominance and poorer outcome using 5' RACE. Blood advances (2024)
Vincent Camus, Pierre-Julien Viailly, Fanny Drieux, Elena-Liana Veresezan, Pierre Sesques, Corinne Haioun, Eric Durot, Martine Patey, Cédric Rossi, Laurent Martin, Vinciane Rainville, Elodie Bohers, Philippe Ruminy, Dominique Penther, Sophie Kaltenbach, Julie Bruneau, Jérôme Paillassa, Olivier Tournilhac, Alexandre Willaume, Chloe Antier, Julien Lazarovici, Emilie Leveque, Pierre Decazes, Stéphanie Becker, David Tonnelet, Alina Berriolo-Riedinger, Philippe Gaulard, Herve Tilly, Thierry Jo Molina, Alexandra Traverse-Glehen, Fabrice Jardin
High PDL1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphoma. Blood advances (2023)
Pierre Decazes, Samy Ammari, Antoine De Prévia, Léo Mottay, Littisha Lawrance, Younes Belkouchi, Baya Benatsou, Laurence Albiges, Corinne Balleyguier, Pierre Vera, Nathalie Lassau
Body Composition to Define Prognosis of Cancers Treated by Anti-Angiogenic Drugs. Diagnostics (Basel, Switzerland) 13 (2) (2023)
Pierre Decazes, Samy Ammari, Younes Belkouchi, Léo Mottay, Littisha Lawrance, Antoine de Prévia, Hugues Talbot, Siham Farhane, Paul-Henry Cournède, Aurélien Marabelle, Florian Guisier, David Planchard, Tony Ibrahim, Caroline Robert, Fabrice Barlesi, Pierre Vera, Nathalie Lassau
Synergic prognostic value of 3D CT scan subcutaneous fat and muscle masses for immunotherapy-treated cancer. Journal for immunotherapy of cancer 11 (9) (2023)
Pierre Decazes, Samy Ammari, Antoine De Prévia, Léo Mottay, Littisha Lawrance, Younes Belkouchi, Baya Benatsou, Laurence Albiges, Corinne Balleyguier, Pierre Vera, Nathalie Lassau
Body Composition to Define Prognosis of Cancers Treated by Anti-Angiogenic Drugs. Diagnostics (Basel, Switzerland) 13 (2) (2023)
Pierre Decazes, Samy Ammari, Antoine De Prévia, Léo Mottay, Littisha Lawrance, Younes Belkouchi, Baya Benatsou, Laurence Albiges, Corinne Balleyguier, Pierre Vera, Nathalie Lassau
Body Composition to Define Prognosis of Cancers Treated by Anti-Angiogenic Drugs. Diagnostics (Basel, Switzerland) 13 (2) (2023)
Florian Eude, Florian Guisier, Mathieu Salaün, Luc Thiberville, Thibault Pressat-Laffouilhere, Pierre Vera, Pierre Decazes
Prognostic value of total tumour volume, adding necrosis to metabolic tumour volume, in advanced or metastatic non-small cell lung cancer treated with first-line pembrolizumab. Annals of nuclear medicine 36 (3) (2022)
Malanie Roy, Agathe Edet-Sanson, Hervé Lefebvre, Pierre Vera, Pierre Decazes
Using 18F-FDG-PET/CT Metrics to Predict Survival in Ra-Dio-Iodine Refractory Thyroid Cancers. Diagnostics (Basel, Switzerland) 12 (10) (2022)
Caroline Dominique, Françoise Callonnec, Anca Berghian, Diana Defta, Pierre Vera, Romain Modzelewski, Pierre Decazes
Deep learning analysis of contrast-enhanced spectral mammography to determine histoprognostic factors of malignant breast tumours. European radiology 32 (7) (2022)
Catherine Thieblemont, Loic Chartier, Ulrich Dührsen, Umberto Vitolo, Sally F Barrington, Jan M Zaucha, Laetitia Vercellino, Maria Gomes da Silva, Inês Patrocínio Carvalho, Pierre Decazes, Pierre-Julien Viailly, Herve Tilly, Alina Berriolo-Riedinger, René-Olivier Casasnovas, Andreas Huettmann, Hajira Ilyas, N George Mikhaeel, Joel Dunn, Anne-Ségolène Cottereau, Christine Schmitz, Lale Kostakoglu, Joseph N Paulson, Tina Nielsen, Michael Meignan
A tumor volume and performance status model to predict outcome before treatment in diffuse large B-cell lymphoma. Blood advances 6 (23) (2022)
Vincent Camus, Cédric Rossi, Pierre Sesques, Justine Lequesne, David Tonnelet, Corinne Haioun, Eric Durot, Alexandre Willaume, Martin Gauthier, Marie-Pierre Moles-Moreau, Chloé Antier, Julien Lazarovici, Hélène Monjanel, Sophie Bernard, Magalie Tardy, Caroline Besson, Laure Lebras, Sylvain Choquet, Katell Le Du, Christophe Bonnet, Sarah Bailly, Gandhi Laurent Damaj, Kamel Laribi, Hervé Maisonneuve, Roch Houot, Adrien Chauchet, Fabrice Jardin, Alexandra Traverse-Glehen, Pierre Decazes, Stéphanie Becker, Alina Berriolo-Riedinger, Hervé Tilly
Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study. Blood advances 5 (19) (2021)
Pierre Decazes, David Tonnelet, Pierre Vera, Isabelle Gardin
Anthropometer3D: Automatic Multi-Slice Segmentation Software for the Measurement of Anthropometric Parameters from CT of PET/CT. Journal of digital imaging 32 (2) (2020)
Pierre Decazes, Vincent Camus, Elodie Bohers, Pierre-Julien Viailly, Hervé Tilly, Philippe Ruminy, Mathieu Viennot, Sébastien Hapdey, Isabelle Gardin, Stéphanie Becker, Pierre Vera, Fabrice Jardin
Correlations between baseline 18F-FDG PET tumour parameters and circulating DNA in diffuse large B cell lymphoma and Hodgkin lymphoma. EJNMMI research 10 (1) (2020)
Pierre Decazes, Pierre Bohn
Immunotherapy by Immune Checkpoint Inhibitors and Nuclear Medicine Imaging: Current and Future Applications. Cancers 12 (2) (2020)
Geoffrey Popinat, Stéphanie Cousse, Lucas Goldfarb, Stéphanie Becker, Isabelle Gardin, Mathieu Salaün, Sébastien Thureau, Pierre Vera, Florian Guisier, Pierre Decazes
Sub-cutaneous Fat Mass measured on multislice computed tomography of pretreatment PET/CT is a prognostic factor of stage IV non-small cell lung cancer treated by nivolumab. Oncoimmunology 8 (5) (2019)
Pierre Decazes, Stéphanie Becker, Mathieu Nessim Toledano, Pierre Vera, Paul Desbordes, Fabrice Jardin, Hervé Tilly, Isabelle Gardin
Tumor fragmentation estimated by volume surface ratio of tumors measured on 18F-FDG PET/CT is an independent prognostic factor of diffuse large B-cell lymphoma. European journal of nuclear medicine and molecular imaging 45 (10) (2018)

Pierre Decazes.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Pierre Decazes